35 related articles for article (PubMed ID: 16019207)
1. Difficulty demonstrating estradiol-mediated Erk1/2 phosphorylation in MCF-7 cells.
Brower SL; Roberts JR; Antonini JM; Miller MR
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):375-85. PubMed ID: 16019207
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
3. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
4. Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells.
Zivadinovic D; Watson CS
Breast Cancer Res; 2005; 7(1):R130-44. PubMed ID: 15642162
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.
Gutzman JH; Nikolai SE; Rugowski DE; Watters JJ; Schuler LA
Mol Endocrinol; 2005 Jul; 19(7):1765-78. PubMed ID: 15746191
[TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
7. Role of ERK1/2 in the differential synthesis of progesterone and estradiol by granulosa cells.
Moore RK; Otsuka F; Shimasaki S
Biochem Biophys Res Commun; 2001 Dec; 289(4):796-800. PubMed ID: 11735115
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
9. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells.
Kairouz R; Parmar J; Lyons RJ; Swarbrick A; Musgrove EA; Daly RJ
J Cell Physiol; 2005 Apr; 203(1):85-93. PubMed ID: 15372466
[TBL] [Abstract][Full Text] [Related]
11. Hydroxylated estrogens (2-OH-E2 AND 4-OH-E2) do not activate cAMP/PKA and ERK1/2 pathways activation in a breast cancer MCF-7 cell line.
Kwiecinska P; Ptak A; Wrobel A; Gregoraszczuk EL
Endocr Regul; 2012 Jan; 46(1):3-12. PubMed ID: 22329816
[TBL] [Abstract][Full Text] [Related]
12. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
[TBL] [Abstract][Full Text] [Related]
14. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
15. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
16. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
Glading A; Koziol JA; Krueger J; Ginsberg MH
Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
[TBL] [Abstract][Full Text] [Related]
17. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
18. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of ERK1/2 phosphorylation as a possible mechanism for the antiproliferative action of 3,4-diOH-PCB3 in the MCF-7 cell line.
Ptak A; Gut P; Błachuta M; Rak A; Gregoraszczuk EŁ
Toxicol Lett; 2009 Oct; 190(2):187-92. PubMed ID: 19619627
[TBL] [Abstract][Full Text] [Related]
20. Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation.
Sirianni R; Chimento A; De Luca A; Casaburi I; Rizza P; Onofrio A; Iacopetta D; Puoci F; Andò S; Maggiolini M; Pezzi V
Mol Nutr Food Res; 2010 Jun; 54(6):833-40. PubMed ID: 20013881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
